Sanjeev K. Khindri

Middlesex, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.

Journal: American journal of respiratory and critical care medicine

Published: February 19, 2025

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.

Journal: American journal of respiratory and critical care medicine

Published: February 19, 2025

Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.

Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.

Journal: Cancer chemotherapy and pharmacology

Published: September 09, 2022

A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects.

A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects.

Journal: Clinical therapeutics

Published: November 07, 2018

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma.

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: November 02, 2018

Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials.

Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: April 25, 2018

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma.

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma.

Journal: The Journal of pharmacology and experimental therapeutics

Published: April 03, 2018

Corrigendum to "Knemometry Assessment of Short-term Growth in Children with Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Cross-over Trial" Clin Ther 2017;39:1191-1199.

Corrigendum to "Knemometry Assessment of Short-term Growth in Children with Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Cross-over Trial" Clin Ther 2017;39:1191-1199.

Journal: Clinical therapeutics

Published: August 28, 2017

Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.

Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.

Journal: Clinical therapeutics

Published: January 13, 2017

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.

Journal: International journal of chronic obstructive pulmonary disease

Published: April 23, 2016

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.

Journal: ERJ open research

Published: December 16, 2015

Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects.

Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects.

Journal: Pulmonary pharmacology & therapeutics

Published: July 21, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026